Gene · 8685
Papers1,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,530
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma. | Nat Commun | 2023 | 38102134 | PubTator, text mining | PubMed |
| Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy. | PLoS One | 2023 | 38096229 | PubTator, text mining | PubMed |
| Recent insight into the role of macrophage in alcohol-associated liver disease: a mini-review. | Front Cell Dev Biol | 2023 | 38094617 | PubTator, text mining | PubMed |
| Interleukin-10 disrupts liver repair in acetaminophen-induced acute liver failure. | Front Immunol | 2023 | 38094302 | PubTator, text mining | PubMed |
| Comprehensive Profiling and Therapeutic Insights into Differentially Expressed Genes in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 38067357 | PubTator, text mining | PubMed |
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype. | Cancers (Basel) | 2023 | 38067234 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade. | Cancer Cell Int | 2023 | 38066642 | PubTator, text mining | PubMed |
| Differences in gene expression profiles in early and late stage rhodesiense HAT individuals in Malawi. | PLoS Negl Trop Dis | 2023 | 38055777 | PubTator, text mining | PubMed |
| An association between ATP7B expression and human cancer prognosis and immunotherapy: a pan-cancer perspective. | BMC Med Genomics | 2023 | 38037104 | PubTator, text mining | PubMed |
| Tumor-associated macrophages: an effective player of the tumor microenvironment. | Front Immunol | 2023 | 38035101 | PubTator, text mining | PubMed |
| Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer. | Lung Cancer (Auckl) | 2023 | 38025400 | PubTator, text mining | PubMed |
| The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis. | Medicina (Kaunas) | 2023 | 38004032 | PubTator, text mining | PubMed |
| Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis. | Biomedicines | 2023 | 38002056 | PubTator, text mining | PubMed |
| [Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis and Lung Adenocarcinoma]. | Zhongguo Fei Ai Za Zhi | 2023 | 37985153 | PubTator, text mining | PubMed |
| The transcriptional and phenotypic characteristics that define alveolar macrophage subsets in acute hypoxemic respiratory failure. | Nat Commun | 2023 | 37978185 | PubTator, text mining | PubMed |
| Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level. | Cell Cycle | 2023 | 37974462 | PubTator, text mining | PubMed |
| Tumour-associated macrophages: versatile players in the tumour microenvironment. | Front Cell Dev Biol | 2023 | 37965573 | PubTator, text mining | PubMed |
| Organ-Specificity of Breast Cancer Metastasis. | Int J Mol Sci | 2023 | 37958607 | PubTator, text mining | PubMed |
| Mechanisms of liver fibrosis in metabolic syndrome. | eGastroenterology | 2023 | 37946713 | PubTator, text mining | PubMed |
| Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer. | J Immunother Cancer | 2023 | 37935567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8685/papers?page=8